Tau‑targeting multifunctional nanocomposite based on tannic acid-metal for near-infrared fluorescence/magnetic resonance bimodal imaging-guided combinational therapy in Alzheimer's disease
Open accessAbstract
Rationale: Alzheimer's disease (AD) is hallmarked by amyloid-β (Aβ) plaques and hyperphosphorylated tau (p-tau) neurofibrillary tangles.While Aβ-centric therapies have shown promise, the complex pathology of AD requires a multifaceted therapeutic approach.The weak association between Aβ levels and cognitive decline highlights the need for alternative theranostic strategies.Currently, oxidative stress and tau hyperphosphorylation are now recognized as critical pathological events in AD.Thus, therapies that concurrently attenuate oxidative stress damage and inhibit tau pathology hold great potential for AD treatment.Methods: Herein, a multifunctional neuron-targeted nanocomposite is devised to realize dual imaging-guided AD therapy, integrating the inhibition of tau pathology and reactive oxygen species (ROS)-neutralizing biofunctions.The construction of the nanocomposite incorporates polyphenolic antioxidants tannic acid (TA)-based nanoparticles carrying manganese ions (Mn 2+ ) and fluorescent dye IR780 iodide (IR780), coupled with a neuron-specific TPL peptide.The resulting IR780-Mn@TA-TPL nanoparticles (NPs) are comprehensively evaluated in both in vitro and in vivo AD models to assess their imaging capabilities and therapeutic efficacy.Results: The nanocomposite facilitates Mn-enhanced magnetic resonance (MR) imaging and near-infrared (NIR) fluorescence imaging.It effectively neutralizes toxic ROS and reduces tau hyperphosphorylation and aggregation.In AD rat models, the nanocomposite restores neuronal density in the hippocampus and significantly improves spatial memory.Conclusions: Such a neuron-targeting multifunctional nanocomposite represents a potential theranostic strategy for AD, signifying a shift towards bimodal imaging-guided treatment approaches.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tau protein serves as a target far less frequently, where systems combine hyperphosphorylated tau targeting with therapies reducing oxidative stress and inhibiting Aβ aggregation.
“Tau protein serves as a target far less frequently, where systems combine hyperphosphorylated tau targeting with therapies reducing oxidative stress and inhibiting Aβ aggregation [64,72].”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [72]
The Conclusions (page unavailable) report that the nanocomposite mitigates oxidative stress and tau hyperphosphorylation, and inhibits subsequent tau aggregation. The Introduction describes substantial prior emphasis on Aβ-centric interventions, but the paper does not establish how much less frequently tau is targeted. It does not report inhibition of Aβ aggregation by this system; the reported aggregation effect concerns tau. (LLM, conf=0.88)
Experimental — accuracy not yet measuredIn animal models, reduction in amyloid plaque burden, decrease in neuroinflammation and oxidative stress, and improvement in cognitive functions in behavioral tests have been demonstrated.
“In animal models, a reduction in the burden of amyloid plaques [58,68,75], a decrease in neuroinflammation and oxidative stress, as well as an improvement in cognitive functions in behavioral tests [58,64,72,73,83,85] have been demonstrated.”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [72]
The Results and Discussion section on in vivo therapeutic outcomes reports improved Y-maze performance and reduced cerebral ROS in treated AD-model rats, supporting the cognitive and oxidative-stress parts of the claim. Our copy does not report a decrease in neuroinflammation or amyloid plaque burden; it measures tau pathology rather than plaque burden. No page number is available in the indexed passages. (LLM, conf=0.86)
Experimental — accuracy not yet measuredAlternative targeting strategies include peptide ligands targeting hyperphosphorylated tau, BBB penetration property, small molecules binding beta-sheet structure, and electrostatic interactions.
“Alternative strategies include the use of peptide ligands targeting hyperphosphorylated tau protein [64] or the property of penetrating the BBB [58,72], as well as small molecules that bind to the beta-sheet structure of amyloid fibrils [83]. In some works, specificity is achieved through electrostatic interactions between the charged surface of Nps and negatively charged amyloid aggregates [68].”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [72]
The Results and Discussion sections report that TPL-peptide-modified nanoparticles bind tau aggregates and cross an in vitro BBB model. But the paper describes TPL as a neuron-targeting peptide; it does not show that the peptide ligand itself specifically targets hyperphosphorylated tau. The claims about amyloid-binding small molecules and electrostatic interactions are attached to other citations in the citing sentence. (LLM, conf=0.85)
Experimental — accuracy not yet measuredThe effectiveness of therapy is confirmed in most studies on cellular models, where a significant increase in survival of neuronal cells upon exposure to toxic concentrations of Aβ is shown.
“The effectiveness of therapy is confirmed in most studies on cellular models, where a significant increase in the survival of neuronal cells upon exposure to toxic concentrations of Aβ is shown [29,64,72,76,77,78,80,83].”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [72]
The Results and Discussion section, under “Mitigation of intracellular oxidative stress” (page unavailable), reports increased PC12 cell viability after nanocomposite treatment. However, the cells were injured with okadaic acid, not exposed to toxic concentrations of Aβ. This source therefore supports improved survival in a cellular model, but not the claimed Aβ-exposure condition. (LLM, conf=0.90)
Experimental — accuracy not yet measuredA number of studies employ multimodal approaches, combining MRI with PET, SPECT, or fluorescence imaging, which compensates for the limitations of each method individually.
“A number of studies employ multimodal approaches, combining MRI with PET [64], SPECT [70,71], or fluorescence imaging [72,75], which compensates for the limitations of each method individually.”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [72]
A significant portion of studies use MRI with contrast agents based on gadolinium, SPIONs, or manganese ions, reflecting the researchers' desire to create platforms potentially applicable in clinical practice.
“A significant portion of the studies use MRI with contrast agents based on gadolinium [70,71], SPIONs [58,63,73,83], or manganese ions [72], reflecting the researchers’ desire to create platforms potentially applicable in clinical practice.”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [72]
Many studies include an antioxidant component aimed at reducing ROS and an anti-inflammatory effect via delivery of immunosuppressants.
“Many studies also include an antioxidant component aimed at reducing the level of ROS [64,72,78,80,83], and an anti-inflammatory effect, implemented through the delivery of immunosuppressants [70,71].”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [72]
Much less frequently, the target of therapy is tau protein, although Chen et al. and Gu et al. demonstrated a reduction in its hyperphosphorylation due to antioxidant action or activation of neuroprotective signaling cascades.
“Much less frequently, the target of therapy is tau protein, although the works of Chen et al. [64] and Gu et al. [72] demonstrated a reduction in its hyperphosphorylation due to antioxidant action or activation of neuroprotective signaling cascades.”
From Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions (2026) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Apoptosis: controlled demolition at the cellular level
Taylor, R. C., Cullen, S. P., & Martin, S. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2312 · Cited by 2,617 · cited 1× · see citing works
“It is known that oxidative stress can induce apoptosis by activating the pro-apoptotic BCL2-associated X (Bax) and the downstream caspase-3 protein (Figure 4A) [48].”
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925 · cited 1× · see citing works
“The etiology of AD includes the aggregation of amyloid-β (Aβ) plaques and the formation of neurofibrillary tangles (NFTs) caused by hyperphosphorylated tau protein [1, 2].”
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651 · see citing works
Gulcin, I., & Alwasel, S. (2023) · Processes · doi:10.3390/pr11082248 · Cited by 1,324 · cited 1× · see citing works
“To further confirm the antioxidative properties of IR780-Mn@TA-TPL NPs, a free radical scavenging experiment was performed using the classic α,α -diphenyl- β -picrylhydrazyl (DPPH) assay [39].”
Kinase inhibitors: the road ahead
Ferguson, F. M., & Gray, N. S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.21 · Cited by 1,009 · cited 1× · see citing works
“In the pathogenic milieu of AD, tau protein undergoes aberrant phosphorylation and then initiates a cascade of self-replicating protein aggregation that forms neurotoxic NFTs, resulting in neuronal injury and synaptic dysfunction [7].”
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Panza, F., Lozupone, M., Logroscino, G., & Imbimbo, B. P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0116-6 · Cited by 965 · see citing works
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P., & Zuo, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2525967 · Cited by 810 · see citing works
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 603 · cited 1× · see citing works
“Although significant efforts have been directed towards Aβ -centric interventions over the past few decades, the weak association between Aβ levels and cognitive decline highlights the urgent need to explore alternative therapeutic approaches [3-6].”
Rizwan, H., Pal, S., Sabnam, S., & Pal, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117148 · Cited by 319 · cited 1× · see citing works
“Excess ROS generation can lead to mitochondrial dysfunction resulting in lower ΔΨm [45, 46].”
Micelles with ultralow critical micelle concentration as carriers for drug delivery
Lü, Y., Yue, Z., Xie, J., Wang, W., Zhu, H. J., Zhang, E., & Cao, Z. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0234-x · Cited by 314 · cited 1× · see citing works
“DSPE-PEG-based nanocarriers are distinguished by their low critical micelle concentration (CMC), stable drug-loading capacity, and functional groups that are amenable to target-specific modification [27].”
Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer’s Disease
Chen, Q., Du, Y., Zhang, K., Liang, Z., Li, J., Yu, H., Ren, R., Feng, J., Jin, Z., Li, F., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b07625 · Cited by 280 · cited 5× · see citing works
“Consistent with previous studies, the expression of Bax and caspase 3 was increased in OA-induced cells (Figure 4B-D) [11].”
InfluentialRole of reactive oxygen species in the progression of Alzheimer’s disease
Bhatt, S., Puli, L., & Patil, C. R. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.004 · Cited by 207 · cited 1× · see citing works
“Concurrently, during the asymptomatic prodromal phase of AD, there is a marked increase in reactive oxygen species (ROS) within the hippocampal and cortical regions, implicating oxidative stress may serve as a precursory event in AD pathogenesis [8-10].”
Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer's disease
Zhang, L., Zhao, P., Yue, C., Jin, Z., Liu, Q., Du, X., & He, Q. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.037 · Cited by 195 · see citing works
Effects of Size and Surface Charge of Polymeric Nanoparticles on in Vitro and in Vivo Applications
Sadat, S. M. A., Jahan, S. T., & Haddadi, A. (2016) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2016.72011 · Cited by 164 · cited 1× · see citing works
“The zeta potential of IR780-Mn@TA-TPL NPs was determined to be -16.5 mV, indicative of their suitability for in vivo applications (Figure 1C) [38].”
InfluentialDSPE-PEG: A Distinctive Component in Drug Delivery System
Che, J., Okeke, C. I., Hu, Z., & Xu, J. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150115144003 · Cited by 156 · cited 1× · see citing works
“…copolymer polyethylene glycol distearoylphosphatidylethanolamine (DSPE-PEG) is frequently employed in nanomedicine engineering due to its good biocompatibility and biodegradability, and it has been approved by the U.S. food and drug administration (FDA) for use in the medical field [26].”
Wang, J.-H., Fan, Y.-D., Tan, Y., Zhao, X., Zhang, Y., Cheng, C.-M., & Yang, M. (2018) · ACS Applied Materials and Interfaces · doi:10.1021/acsami.8b15452 · Cited by 148 · cited 1× · see citing works
“The etiology of AD includes the aggregation of amyloid-β (Aβ) plaques and the formation of neurofibrillary tangles (NFTs) caused by hyperphosphorylated tau protein [1, 2].”
Self-citationTannic Acid–Iron Complex-Based Nanoparticles as a Novel Tool against Oxidative Stress
Pucci, C., Martinelli, C., Pasquale, D. D., Battaglini, M., di Leo, N., Degl'innocenti, A., Gümüş, M. B., Drago, F., & Ciofani, G. (2022) · ACS Applied Materials and Interfaces · doi:10.1021/acsami.1c24576 · Cited by 141 · cited 3× · see citing works
“Additionally, the catechol moieties within TA facilitate strong chelating interaction with metal ions for magnetic resonance imaging (MRI) that could achieve non-invasive imaging of brain tissues in AD with a high spatial resolution [18, 21].”
Non-invasive photobiomodulation treatment in an Alzheimer Disease-like transgenic rat model
Yang, L., Wu, C., Parker, E., Li, Y., Dong, Y., Tucker, L. D., Brann, D. W., Lin, H. W., & Zhang, Q. (2022) · Theranostics · doi:10.7150/thno.70756 · Cited by 137 · cited 1× · see citing works
“Therefore, we introduced the Y-maze behavior test to explore spatial learning and memory in AD rats by recording the frequency and duration they spent in the new arm [52, 53].”
Self-citationGuo, Q., Xu, S., Yang, P., Wang, P., Lü, S., Sheng, D., Qian, K., Cao, J., Lü, W., & Zhang, Q. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.039 · Cited by 103 · cited 2× · see citing works
“To further tailor the nanocomposite for targeted AD therapy, we functionalized the NPs with a fusion peptide TPL ( l -TGNYKALHPHNGGGGGHLNILSTL WKYR) [33] that comprises a blood brain barrier (BBB)-penetrating peptide TGN and a neuron binding peptide Tet1 through a four-glycine linker, yielding…”
Self-citationLi, S., Johnson, J. S., Peck, A. S., & Xie, Q. R. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-016-1115-2 · Cited by 100 · cited 1× · see citing works
“The architecture of the nanocomposite utilizes the self-assembly of DSPE-PEG polymer molecules into nanomicelles with hydrophobic cavities that encapsulate IR780, a near-infrared (NIR) fluorescent dye that can be used for in vivo imaging due to its high photostability and minimal phototoxicity [32].”
Plant-Derived Antioxidants Protect the Nervous System From Aging by Inhibiting Oxidative Stress
Cui, X., Lin, Q.-L., & Liang, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00209 · Cited by 95 · cited 1× · see citing works
“Natural polyphenolic antioxidants are increasingly recognized for their potential in AD therapy, attributable to their widespread availability, good biocompatibility and potent antioxidative properties [12].”
Daré, R. G., Nakamura, C., Ximenes, V., & Lautenschlager, S. O. (2020) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2020.08.019 · Cited by 92 · cited 1× · see citing works
“Tannic acid (TA), a polyphenol comprised of a glucose core esterified with ten gallic acid units, stands out for its multifaceted therapeutic possibilities in AD [13-16].”
Fernsebner, K., Zorn, J., Kanawati, B., Walker, A., & Michalke, B. (2014) · Metallomics · doi:10.1039/c4mt00022f · Cited by 92 · cited 1× · see citing works
“Several works have employed Mn-enhanced MRI in preclinical animal models of neurodegenerative diseases through locally injected MnCl 2 to enhance of the contrast in the brain [23, 24].”
Kamat, P. K., Tota, S., Saxena, G., Shukla, R., & Nath, C. (2010) · Brain Research · doi:10.1016/j.brainres.2009.10.064 · Cited by 88 · cited 2× · see citing works
“…OA (300 ng in 1.5 µL of saline) or saline (0.9% NaCl for medical use, 1.5 µL) was stereotaxically microinjected into the right dorsal hippocampus (AP -3.8 mm, ML -2.5 mm, and DV -3.2 mm, according to the Rat Brain Paxinos Atlas) to establish the AD model and sham groups, respectively [11, 51].”
InfluentialJi, W., Li, Y., Peng, H., Zhao, R., Shen, J., Wu, Y., Wang, J., Hao, Q., Lü, Z., Yang, J., et al. (2021) · Advanced Materials · doi:10.1002/adma.202105711 · Cited by 79 · cited 1× · see citing works
“Mouse brain microvascular endothelial (bEnd.3) cells were cultured on the upper layer for 7 days to form a monolayer layer of endothelial barrier (Figure S14B), and PC12 cells were seeded in the basolateral side [42].”
Sun, H., Zhong, Y., Zhu, X., Liao, H., Lee, J., Chen, Y., Ma, L., Ren, J., Zhao, M., Tu, M., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c10690 · Cited by 69 · cited 1× · see citing works
“In addition, tau pathogenesis in AD involves two key serine/threonine-specific protein kinases, protein kinase B (AKT) and its downstream kinase glycogen synthase kinase 3β (GSK3β) [49].”
Tau-Targeted Multifunctional Nanoinhibitor for Alzheimer’s Disease
Zhu, L., Xu, L., Wu, X., Dèng, F., Ma, R., Liu, Y., Huang, F., & Shi, L. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00257 · Cited by 59 · see citing works
Zhang, Q., Yin, B.-H., Huang, Y.-Y., Gu, Y., Yan, J.-X., Chen, J.-R., Li, C.-Q., Zhang, Y., Wong, S. H. D., & Yang, M. (2023) · Biosensors & bioelectronics · doi:10.1016/j.bios.2023.115270 · Cited by 51 · cited 1×
“Thereafter, we induced an AD cell model by subjecting PC12 cells to 50 nM okadaic acid (OA) for 12 h, which provoked excessive neuronal ROS production, along with abnormal tau protein hyperphosphorylation and aggregation [43].”
Self-citationAntioxidant and anti-aging carbon quantum dots using tannic acid
Son, M. H., Park, S., & Jung, Y. (2021) · Nanotechnology · doi:10.1088/1361-6528/ac027b · Cited by 50 · cited 1×
“The dense hydroxyl groups of TA confer a robust capacity to neutralize deleterious ROS such as hydroxyl radical (•OH), hydrogen peroxide (H 2 O 2 ), and superoxide anions (O 2 •− ) [17, 18].”
Molecular hairpin: a possible model for inhibition of tau aggregation by tannic acid.
Yao, J.-L., Gao, X., Sun, W.-L., Yao, T.-M., Shi, S., & Ji, L. (2013) · Biochemistry · doi:10.1021/bi400240c · Cited by 47 · cited 1× · see citing works
“…structure of TA enables it to recognize the R3 peptide region of tau protein by forming hydrogen bond-mediated hairpin-like configurations, which is postulated to impede pathological conformational transitions and consequently mitigate the aggregation of neurotoxic tau filaments [19, 20].”
Qi, Y., Li, J.-R., Nie, Q., Gao, M., Yang, Q.-H., Li, Z.-M., Li, Q., Han, S., Ding, J., Li, Y.-Q., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120952 · Cited by 45 · cited 1× · see citing works
“Yet, TA suffers from the inherent limitations such as poor physiological stability and rapid degradation, which prevent it from reaching efficacious concentrations within the cerebral milieu and thereby limit its therapeutic potential [25].”
Zhang, Q., Yin, B.-H., Hao, J.-H., Ma, L.-J., Huang, Y.-Y., Shao, X.-Y., Li, C.-Q., Chu, Z., Yi, C., Wong, S. H. D., et al. (2022) · Aggregate · doi:10.1002/agt2.195 · Cited by 44 · cited 1×
“The former aids in swiftly and effectively monitoring NPs accumulation at the lesion site via in vivo NIR FL imaging, thereby facilitating the investigation of dosage regimens to optimize the therapeutic efficacy of NPs [35, 36].”
Self-citationSamluk, Ł., Ostapczuk, P., & Dziembowska, M. (2022) · Molecular Biology of the Cell · doi:10.1091/mbc.e21-11-0553 · Cited by 41 · cited 1× · see citing works
“Mitochondrial superoxide constitutes the primary ROS species contributing to neuronal oxidative stress and subsequent cell death [44].”
Azria, D., Blanquer, S., Verdier, J., & Belamie, E. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01599b · Cited by 41 · cited 2× · see citing works
“Several works have employed Mn-enhanced MRI in preclinical animal models of neurodegenerative diseases through locally injected MnCl 2 to enhance of the contrast in the brain [23, 24].”
Tannic acid/Mg2+-based versatile coating to manipulate the osteoimmunomodulation of implants.
He, M., Gao, X., Fan, Y.-D., Xie, L., Yang, M., & Tian, W. (2021) · Journal of materials chemistry. B · doi:10.1039/d0tb01577f · Cited by 38 · cited 1× · see citing works
“Tannic acid (TA), a polyphenol comprised of a glucose core esterified with ten gallic acid units, stands out for its multifaceted therapeutic possibilities in AD [13-16].”
Self-citationByun, H., Jang, G. N., Hong, M., Yeo, J., Shin, H., Kim, W. J., & Shin, H. (2022) · Nano Convergence · doi:10.1186/s40580-022-00338-2 · Cited by 37
Tau protein aggregation: Key features to improve drug discovery screening
Giovannini, J., Smeralda, W., Jouanne, M., Santos, J. S. O., Catto, M., & Voisin‐Chiret, A. S. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.009 · Cited by 33 · cited 1× · see citing works
“The screening was based on the thioflavin S (ThS) fluorescence assay where the emission of ThS was strongly increased upon binding to β -sheet structures present in tau aggregates [11, 40].”
A PEG-tannic acid decorated microfiltration membrane for the fast removal of Rhodamine B from water
Shi, P., Hu, X., Wang, Y.-T., Duan, M., Fang, S., & Chen, W. (2018) · Separation and Purification Technology · doi:10.1016/j.seppur.2018.06.075 · Cited by 32 · cited 1×
“Moreover, Fourier-Transform Infrared (FT-IR) spectrum revealed that the strength of the phenolic hydroxyl group of TA at 3334 cm -1 was significantly weakened upon the formation of NPs (Figure 1B and S3), which hinted at intermolecular hydrogen bonding between TA and the PEG segments [29, 30].”
Synthesis and characterization of tannic acid–PEG hydrogel via Mitsunobu polymerization
Chen, C., Geng, X., Pan, Y., Ma, Y.-N., Ma, Y.-X., Gao, S., & Huang, X.-J. (2020) · RSC Advances · doi:10.1039/c9ra09229c · Cited by 31 · cited 1× · see citing works
“In our study, we address this challenge by aligning TA at the nanoparticle interface through hydrogen bonding with PEG [29-31], thus devising an alternative encapsulation strategy for the preparation of TA-based nanotherapeutics.”
Lu, S.-J., Xia, R., Wang, J., Pei, Q., Xie, Z.-G., & Jing, X. (2021) · ACS Applied Materials and Interfaces · doi:10.1021/acsami.1c12353 · Cited by 30 · cited 1× · see citing works
“Additionally, the catechol moieties within TA facilitate strong chelating interaction with metal ions for magnetic resonance imaging (MRI) that could achieve non-invasive imaging of brain tissues in AD with a high spatial resolution [18, 21].”
Hamidi, N., Nozad, A., Milan, H. S., & Amani, M. (2019) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.01.007 · Cited by 28 · cited 1× · see citing works
“Therefore, we introduced the Y-maze behavior test to explore spatial learning and memory in AD rats by recording the frequency and duration they spent in the new arm [52, 53].”
Sachdeva, A. K., & Chopra, K. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.08.024 · Cited by 27 · cited 1× · see citing works
“We established an in vivo AD model by intracerebral administration of OA into rats to induce oxidative stress damage and tau hyperphosphorylation within the hippocampus (Figure 5A) [11, 50, 51].”
Wang, J., Gu, Y., Liu, X., Fan, Y., Zhang, Y., Yi, C., Cheng, C., & Yang, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810885 · Cited by 27 · cited 1× · see citing works
“Although significant efforts have been directed towards Aβ -centric interventions over the past few decades, the weak association between Aβ levels and cognitive decline highlights the urgent need to explore alternative therapeutic approaches [3-6].”
Self-citationSahiner, N., & Sengel, S. B. (2016) · doi:10.1016/j.colsurfa.2016.08.014 · Cited by 26 · cited 1×
“However, the hydrophilic nature of TA poses a challenge for encapsulation within DSPE-PEG nanocarriers using standard nanoprecipitation techniques [28].”
Hu, Y., Hu, X., Lu, Y.-L., Shi, S., Yang, D., & Yao, T.-M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00508 · Cited by 25 · cited 1× · see citing works
“…structure of TA enables it to recognize the R3 peptide region of tau protein by forming hydrogen bond-mediated hairpin-like configurations, which is postulated to impede pathological conformational transitions and consequently mitigate the aggregation of neurotoxic tau filaments [19, 20].”
Manganese-Enhanced Magnetic Resonance Imaging: Application in Central Nervous System Diseases
Yang, J., & Li, Q.-Q. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00143 · Cited by 21 · cited 1× · see citing works
“Among MRI contrast agents, manganese (Mn) exhibits strong paramagnetism and significantly shortens the T1 relaxation time, making it an excellent candidate for MRI applications [22].”
He, M., Yang, B., Huo, F., Xie, L., Yang, M., & Tian, W. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00953b · Cited by 16 · see citing works
Self-citationZhang, Q., Li, C., Yin, B.-H., Yan, J.-X., Gu, Y., Huang, Y.-Y., Chen, J.-R., Lao, X.-X., Hao, J.-H., Yi, C., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.08.029 · Cited by 14 · cited 1×
“Concurrently, during the asymptomatic prodromal phase of AD, there is a marked increase in reactive oxygen species (ROS) within the hippocampal and cortical regions, implicating oxidative stress may serve as a precursory event in AD pathogenesis [8-10].”
Self-citationHuang, Y.-Y., Zhang, Q., Lam, C. Y. K., Li, C., Yang, C., Zhong, Z., Zhang, R.-L., Yan, J.-X., Chen, J.-R., Yin, B.-H., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c03796 · Cited by 14 · cited 1× · see citing works
“The former aids in swiftly and effectively monitoring NPs accumulation at the lesion site via in vivo NIR FL imaging, thereby facilitating the investigation of dosage regimens to optimize the therapeutic efficacy of NPs [35, 36].”
Self-citationMitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease
Moreira, P. I. (2010) · European Neurological Review · doi:10.17925/enr.2010.05.01.17 · Cited by 13 · cited 1× · see citing works
“Excess ROS generation can lead to mitochondrial dysfunction resulting in lower ΔΨm [45, 46].”
Drug-Releasing Tannic Acid-Mediated Adhesive PEG Hydrogel for Porous Titanium Implants
Bubpamala, T., Promoppatum, P., & Pholpabu, P. (2023) · ACS Omega · doi:10.1021/acsomega.3c06966 · Cited by 13 · cited 2× · see citing works
“Moreover, Fourier-Transform Infrared (FT-IR) spectrum revealed that the strength of the phenolic hydroxyl group of TA at 3334 cm -1 was significantly weakened upon the formation of NPs (Figure 1B and S3), which hinted at intermolecular hydrogen bonding between TA and the PEG segments [29, 30].”
Gao, H., Xiu, M. Q., Wang, M. Y., Zhan, B. Y., Deng, X., Xu, Y.-J., Dai, D.-M., Liu, X., Si, C.-D., & Liu, G. (2019) · ChemistrySelect · doi:10.1002/slct.201804044 · Cited by 10 · cited 1×
“…in the formation of IR780-Mn@TA NPs. X-ray photoelectron spectroscopy (XPS) analysis of O 1s spectra suggested the formation of O-Mn with a binding energy located at 530.26 eV, indicating the presence of coordination between Mn and the hydroxyl groups of TA in IR780-Mn@TA NPs (Figure S4) [37].”
Influential
Flagged first, then by citations
Research works printed but not linked: 1
- [34]Xu S Yang P Qian K Li Y Guo Q Wang P Modulating autophagic flux via ROS-responsive targeted micelles to restore neuronal proteostasis in Alzheimer's disease Bioact Mater 2022 11 300 316 34977433 PMC8668445
Cited by
Sorted by citations
Harnessing Photo‐Energy Conversion in Nanomaterials for Precision Theranostics
Shi, J., Fan, Y., Zhang, Q., Huang, Y., & Yang, M. (2025) · Advanced Materials · doi:10.1002/adma.202501623 · Cited by 26 · see citing works
Self-citationTannic acid: A link between metallic elements and biomedical applications
Huang, K., Liu, H., Zhang, H., Zhang, X., Jiang, H., Liu, X., & Wang, X. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217193 · Cited by 18 · see citing works
Programmable next-generation supramolecular self-assembled materials as drug delivery systems
Fu, H.-W., Gao, W., Tang, Y.-X., Liu, X.-L., Wang, M., Zhang, J.-C., Liu, T.-Q., & Zhang, J.-H. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.01.040 · Cited by 14 · see citing works
“This includes engineering small, lipophilic nanoparticles or applying external stimuli like focused ultrasound or light [229].”
Biohybrid catalysis in biomedicine
Li, X., Zhang, Y., He, A., Li, Q., Wang, S., Shan, J., Li, S., Yang, D., Wu, G., Xiu, W., et al. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217003 · Cited by 14 · see citing works
Self-citationYu, D., Zhang, H., Du, X.-B., Ren, J.-S., & Qu, X.-G. (2025) · Small · doi:10.1002/smll.202410063 · Cited by 13 · see citing works
Wang, J., Gao, X., Feng, L., Zhang, D., Lv, S., Li, X., Liu, Q.-J., Yu, D.-K., Xing, M.-M., Li, D., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113904 · Cited by 11
Jin, J., Cen, Q., Wang, H., Xin, Y., Feng, J., Cui, Y., Li, J., You, Z., Jing, F., Yu, Y., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107283 · Cited by 10 · see citing works
Material-based neuroimaging and biomarker detection for central nervous system disorder
Yu, L., Zhu, Y., Zheng, X., Huang, R., Song, S., Liu, Y., Liu, Z., Chen, B., & Zhu, R. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102615 · Cited by 4 · see citing works
“[120].”
Pillarisetti, S., Alfieri, R., Palumbo, P., Sarmento, B., Celia, C., & Fresta, M. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114933 · Cited by 4 · see citing works
Ho, W. K. H., Zhang, Q., Zhorabe, F., Yan, J.-X., Gu, Y., Wang, S.-J., Yi, C., Zhang, Y., & Yang, M. (2025) · Journal of materials chemistry. B · doi:10.1039/d5tb00632e · Cited by 4
Self-citationAn albumin-prodrug injectable formulation for synergistic cancer immunotherapy.
Li, Y., Lu, Y.-T., Zhu, X.-L., Wu, T., Ali, K., Zhang, H., Ma, Z.-Q., Liu, H., Wang, H.-X., Zhu, H.-P., et al. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.02.012 · Cited by 3 · see citing works
Bhukta, P., Sahu, P. K., & Acharya, B. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100495 · Cited by 2 · see citing works
Zhou, H., Yang, H., Vijver, M. G., & Peijnenburg, W. J. G. M. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.142090 · Cited by 1 · see citing works
Nanomaterials for Alzheimer’s disease: emerging strategies in diagnosis and therapy
Na, Y., Bai, J., Zhang, N., Geng, F., & Wang, X.-J. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04281-w · Cited by 2 · see citing works
“Under physiological conditions, Tau stabilizes neuronal microtubules; however, hyperphosphorylation reduces its binding affinity, leading to microtubule destabilization, formation of neurofibrillary tangles, and ultimately impaired axonal transport, synaptic loss, and neurode-generation [139–141].”
Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions
Zorkina, Y., Abramova, O., Zubkov, E., Gurina, O., & Ushakova, V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083560 · Cited by 1 · see citing works
“A significant portion of the studies use MRI with contrast agents based on gadolinium [70,71], SPIONs [58,63,73,83], or manganese ions [72], reflecting the researchers’ desire to create platforms potentially applicable in clinical practice.”
InfluentialShao, Z., Zhang, W., Zheng, C., Huang, P., Liu, J.-X., Yi, X., Song, X., Chen, Z., Zheng, W., & Chen, X.-Y. (2026) · Materials Today · doi:10.1016/j.mattod.2026.103421 · Cited by 1 · see citing works
Cai, M., Wang, X.-D., Sun, S., Yuan, Z.-X., Wang, Y., Hua, X., & Yuan, X. (2026) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.67.3.13 · Cited by 1
Xue, R., Wang, F., Zhang, B., Wu, J., Zhang, N., & Sun, C. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123970 · Cited by 1 · see citing works
Zhu, T., Deng, X., lu, J., Zhou, X., Wang, Y., Xu, D., Song, J., Xie, X., & Chen, C. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261495962
Self-Assembled EGCG@Zn Fluorescent Nanocomplexes for Sensitive Detection of Amyloid-β42
Andleeb, S., Raza, J., Younas, F., Iftikhar, M., Sun, X.-F., Wu, Y.-G., Fatima, M., & Faizan, M. (2026) · Journal of Fluorescence · doi:10.1007/s10895-026-04943-w
Ren, Z., Yue, Q., Gao, N., Hao, Q.-L., Huo, Y., Li, C., Leng, X., Sun, L., Hoi, M. P. M., Han, H., et al. (2026) · Advanced Science · doi:10.1002/advs.77545 · Cited by 1 · see citing works
“In addition, imaging-oriented theranostic approaches have been explored to monitor Tau pathology progression and therapeutic response [ 19 ].”
Wu, Y.-Q., Wang, M.-K., Li, T.-P., Huang, Z.-H., Wu, M., Sun, T.-T., & Cong, H.-L. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s630802
“91 Ultrasound-responsive carriers exploit inertial cavitation (microbubbles) for transient BBB opening or piezoelectric materials (eg, MoS 2 @Bi 2 S 3 ) for non-thermal ROS generation and antioxidant catalysis.”
Na, Y., Liu, C., Bi, X., Liu, S., Xing, Y., Zhang, B.-H., Liu, T.-F., Zhang, N., & Geng, F. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103617
“Overcoming the BBB remains a major bottleneck for CNS drug delivery, and receptor-mediated transcytosis (RMT) has been validated as one of the most practical and effective pathways to address this challenge [32,33].”
Gawade, A., Kuchekar, A. B., & Pujari, R. (2026) · Advanced Therapeutics · doi:10.1002/adtp.70159
- Authors
- Gu, Y., Zhang, Q., Huang, H., Ho, K. H. W., Zhang, Y., Yi, C., Zheng, Y., Chang, R. C. C., Wang, E. S., & Yang, M.
- Affiliations
- Hong Kong Polytechnic University (HK)
- Sun Yat-sen University (CN)
- University of Hong Kong (HK)
- Corresponding author
- Zhang, Qin
- Yang, Mo
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2024
- Volume
- 14
- Issue
- 16
- Pages
- 6218-6235
- ISSN
- 1838-7640 (ISSN-L)
- PMC
- PMC11488108
- OpenAlex
- W4403545526
- Cited by
- 27
- References
- 52
- Citations by year
- 2026: 17 · 2025: 10
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Theranostics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PolyU Institutional Research Archive (Hong Kong Polytechnic University) (publishedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- Alzheimer's disease, tau hyperphosphorylation, manganese-enhanced MRI, near-infrared fluorescence imaging, dual-modality imaging, reactive oxygen species scavenging, oxidative stress, IR780, tau aggregation, spatial memory, hippocampus
- MeSH terms
- Theranostic Nanomedicine, Alzheimer Disease, Animals, Combined Modality Therapy, Disease Models, Animal, Humans, Magnetic Resonance Imaging, Manganese, Neurons, Tannins, tau Proteins, Reactive Oxygen Species, Oxidative Stress, Rats, Nanocomposites, Polyphenols, Optical Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review